They have just announced a Turpin like secondary ,,,...
Actually my statement is incorrect,,,,Turpin prefers to do secondary before clinical trial results are known....so far his batting average is 1000..Trial results have never been positive
KERX $90m cash after offering. $65m from Japan when drug is approved. "Game changer" drug status. Let the buy out bidding begin!
Sentiment: Strong Buy